<div>
    <ul>
        <li>An agreement between two manufacturers whereby one manufacturer (licensor) supplies a drug product to another manufacturer (licensee) for sale under the second manufacturerâ€™s name.</li>
    </ul>
</div>
<div class="row alert alert-info" role="alert" aria-live="polite">
    <span>
        Note: A new Dossier ID is required if the proposed product(s) are not previously approved
        (i.e. no dossier ID already exists).  Except in the case of a replace source cross-licensing.
        Contact Health Canada for more information (eReview@hc-sc.gc.ca).
        <p>On the RA template: Use the company ID for new owner (licensee) and use existing dossier ID,
            unless a new dossier ID was assigned by Health Canada.
    </span>
</div>